Target intelligence / Profile preview

RNA, U6 small nuclear 172, pseudogene (RNU6-172P)

Target
RNU6-172P
Molecular classification
Other (Pseudogene)
01

Overview

RNU6-172P (RNA, U6 small nuclear 172, pseudogene) is a non-coding, genomically-encoded pseudogene corresponding to a defective or relic version of the U6 small nuclear RNA gene. Pseudogenes such as RNU6-172P do not encode functional snRNA and are not translated into proteins, nor do they act as biochemical receptors, enzymes, or signaling molecules[6][7]. The original U6 small nuclear RNA (snRNA) is an essential non-coding RNA involved in the splicing of pre-mRNA in the spliceosome[1][3][5]; however, RNU6-172P lacks the proper sequence or regulatory elements for expression and functional activity in splicing. Sequence analyses have revealed that U6 snRNA pseudogenes often bear sequence similarity to authentic U6 RNAs but contain deletions, duplications, or mutations that render them inactive[7]. The pseudogene status means this locus is generally biologically silent and unlikely to have direct clinical or therapeutic relevance. There are no known drugs, clinical biomarkers, or disease implications specifically associated with RNU6-172P[6]. Any significance is limited to potential roles as genomic evolutionary markers or rare regulatory sequences, but this is not established for RNU6-172P. Notes on correctness: If referenced as a receptor, enzyme, transporter, or other druggable target, this is incorrect; RNU6-172P is a pseudogene lacking any known therapeutic or biological activity. It should be distinguished from genuine U6 snRNA gene loci (such as RNU6-1)[2][3], which encode the functional RNA used in nuclear splicing.

Other names
RNU6-172PU6 small nuclear RNA pseudogene 172

Beyond the preview

Go deeper on RNA, U6 small nuclear 172, pseudogene (RNU6-172P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 172, pseudogene (RNU6-172P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call